Clinical trials recruiting for Gastric (Stomach) Cancer
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| BHB810 | 1 |
| DA-3501 | 1 |
| Riluzole | 1 |
| TCC1727 tablet 120mg | 1 |
| TCC1727 tablet 160mg | 1 |
| TCC1727 tablet 90mg | 1 |
| benmelstobart Injection | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 2 |
| Massachusetts | 1 |
| Virginia | 1 |
Top cities
Self-screener
Recruiting trials
- A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma
- An Phase Ib/II Clinical Trial of TCC1727 Combination Therapy in Advanced Solid Tumors
- Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
- Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
- Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
- Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Related conditions
Trials recruiting for Gastric (Stomach) Cancer often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Gastric (Stomach) Cancer trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.